On December 22, 2021, the Food and Drug Administration (FDA) granted Emergency Use Authorization (EUA) for Pfizer’s Paxlovid, an oral medication regimen for early “treatment” of mild to moderate COVID-19. Paxlovid is a combination drug therapy consisting of Pfizer’s Nirmatrelvir co-packaged with Ritonavir (Norvir), a drug used in the treatment …
This post was created with our nice and easy submission form. Create your post!
Comments
Loading…